DocumentCode
2943107
Title
Combination effects of repetitive pulsed magnetic stimulation and tyrosine kinase inhibitor imatinib for chronic myeloid leukemia cell line TCC-S
Author
Yamaguchi, S. ; Sekino, M. ; Sato, Y. ; Ueno, S.
Author_Institution
Univ. of Tokyo, Tokyo
fYear
2006
fDate
8-12 May 2006
Firstpage
550
Lastpage
550
Abstract
In the present study combination effects of RPMS and the anticancer agent were examined by using human leukemia -derived cell line TCC-S and its molecular target drug (selective tyrosin kinase inhibitor) imtinib.
Keywords
biological effects of fields; biological tissues; cellular effects of radiation; inhibitors; magnetic field effects; TCC-S cell line; anticancer agent; chronic myeloid leukemia; combination effects; repetitive pulsed magnetic stimulation; tyrosine kinase inhibitor imatinib; Amino acids; Biomembranes; Cells (biology); Drugs; EMP radiation effects; Eddy currents; Humans; Inhibitors; Magnetic flux; Magnetic stimulation;
fLanguage
English
Publisher
ieee
Conference_Titel
Magnetics Conference, 2006. INTERMAG 2006. IEEE International
Conference_Location
San Diego, CA
Print_ISBN
1-4244-1479-2
Type
conf
DOI
10.1109/INTMAG.2006.376274
Filename
4261983
Link To Document